HALIFAX, July 16 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,
NASDAQ: MMIRF), a developer and marketer of rapid diagnostics, announced today
that it received a Notice of Allowance from the United States Patent and
Trademark Office for its rapid flow-through test (RFT) methodology, the
technology platform its rapid tests are built on.
